TAKEDA PHARMACEUTICALS AMERICA, INC. for TAKEDA PHARMACEUTICALS AMERICA INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 3, 2011 | $400,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Jan 19, 2012 | $350,000 | Replaced |
| 3rd Quarter - Amendment | Jan 19, 2012 | $510,000 | Yes |
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Agriculture; Labor, HHS; Commerce and Homeland Security Departments Appropriation Bills; Continuing Resolution; Budget Control Act of 2011; Joint Committee on Deficit Reduction
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA WILKINSON | — |
Copyright/Patent/Trademark CPT
S. 23 Patent Reform Act of 2011; S. 27 Preserve Access to Affordable Generics; general patent settlement issues; HR 1249, America Invents Act; S. 968, the PROTECT IP Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA WILKINSON | — |
Medical/Disease Research/Clinical Labs MED
Regenerative Medicines Promotion Act; Gastrointestinal and Motility Disorders Research Enhancement Act (H.R. 2239); depression screening, end stage renal disease;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA WILKINSON | — |
Trade (domestic/foreign) TRD
Importation issues; Preserve Access to Affordable Generics Act; S. 319 Pharmaceutical Market Access and Drug Safety Act;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA WILKINSON | — |
Manufacturing MAN
Prescription Drug User Fee Act Reauthorization; FDA Sentinel Pilot; S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R.2245, Preserving Access to Life-Saving Medications Act of 2011; DTC advertising; HR 1483 Drug Import Safety legislation; drug pedigree, supply chain/shortage issues; Safeguarding Americas Pharmaceuticals Act; counterfiet and serialization;
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBORAH LYNN WALTER New | — |
| ANDREA WILKINSON | — |
Taxation/Internal Revenue Code TAX
Implementaton of ACA Pharmaceutical fee; corporate tax reform, R&D tax credit extension; Debt commissions recommendations; Reid/Baucus Lundgren repeal of Patient Protection and Affordable Care Act; Innovate America Act; Ryan Roadmap; Debt and deficit negotiations; foreign tax reforms; HR. 2190/S.1206 Medicare Drug Savings Act of 2011; S. 1577 R&D Credit Bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANDREA WILKINSON | — |
Health Issues HCR
General comparative effectiveness issues, health reform and the un/underinsured, chronic disease legislation (diabetes, mental health, obesity, CKD), value based insurance design, quality of care, adhereance, ACA implementation; Anit-Gout USP matters; PCORI; Essential benefits package, ESRD bundling implementation; coverage gap, S. 371/HR741 Bill to prohibit authorized generics, Debt and Deficit negotiations
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA ELIZABETH CLINE | — |
| DEBORAH LYNN WALTER | — |
| ANDREA WILKINSON | — |
Medicare/Medicaid MMM
340B-1 and AMP, Part D coverage gap discount program implelmentation, Protected Classes, Comparative Effectiveness, general Medicare/Medicaid expansions and reform; Value based Purchasing Program; End Stage Renal Disease final rules; TRICARE, HR 457 Medicare Decisions Accountability Act of 2011 (IPAB repeal), Medicare Evident Development and Coverage Ad Com.; Medicare Payment Advisory Commission; S. 31 Prescription Drug and Health Improvement Act; Debt and deficit negotiations S. 44 Medicare Prescription Drug Price Negotiation Act; CMS proposed Medicare Advantage; S 373 Fair Prescription Drug Competition Act; Ryan Roadmap; HR. 2190/S.1206 Medicare Drug Savings Act of 2011; the Medicaid Improvement and State Empowerment Act; Academic Detailing;
| Lobbyist | Covered position, as disclosed |
|---|---|
| LAURA ELIZABETH CLINE | — |
| DEBORAH LYNN WALTER | — |
| ANDREA WILKINSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.